Abstract
Reverse transcriptase (RT), an essential enzyme for HIV-1 (human immunodeficiency virus type-1) life cycle, is a key target in drug discovery efforts against HIV-1 infection. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are very specific to HIV-1 RT and have relatively less toxicity than the nucleoside reverse transcriptase inhibitors (NRTIs). However, the rapid emergence of drug-resistant viral strains has limited the therapeutic efficacy of these inhibitors. In this review, recent advances in computer-aided drug design (CADD) for design of new compounds against HIV-1 RT based on ligand-based drug design (LBDD) using 2D-and 3D-QSAR approaches, structure-based drug design (SBDD) with the combination of molecular docking, virtual screening and de novo drug design, molecular simulations and particular interaction calculated from quantum chemical calculations are discussed. Their successful applications are also highlighted.
Keywords: Human immunodeficiency virus type-1, computer-aided drug design, non-nucleoside reverse transcriptase inhibitors, structure-based drug design, ligand-based drug design, quantum chemical calculations, molecular simulation
Current Computer-Aided Drug Design
Title: Recent Advances in NNRTI Design: Computer-Aided Molecular Design Approaches
Volume: 5 Issue: 3
Author(s): Pornpan Pungpo, Auradee Punkvang, Patchreenart Saparpakorn, Peter Wolschann and Supa Hannongbua
Affiliation:
Keywords: Human immunodeficiency virus type-1, computer-aided drug design, non-nucleoside reverse transcriptase inhibitors, structure-based drug design, ligand-based drug design, quantum chemical calculations, molecular simulation
Abstract: Reverse transcriptase (RT), an essential enzyme for HIV-1 (human immunodeficiency virus type-1) life cycle, is a key target in drug discovery efforts against HIV-1 infection. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are very specific to HIV-1 RT and have relatively less toxicity than the nucleoside reverse transcriptase inhibitors (NRTIs). However, the rapid emergence of drug-resistant viral strains has limited the therapeutic efficacy of these inhibitors. In this review, recent advances in computer-aided drug design (CADD) for design of new compounds against HIV-1 RT based on ligand-based drug design (LBDD) using 2D-and 3D-QSAR approaches, structure-based drug design (SBDD) with the combination of molecular docking, virtual screening and de novo drug design, molecular simulations and particular interaction calculated from quantum chemical calculations are discussed. Their successful applications are also highlighted.
Export Options
About this article
Cite this article as:
Pungpo Pornpan, Punkvang Auradee, Saparpakorn Patchreenart, Wolschann Peter and Hannongbua Supa, Recent Advances in NNRTI Design: Computer-Aided Molecular Design Approaches, Current Computer-Aided Drug Design 2009; 5 (3) . https://dx.doi.org/10.2174/157340909789054685
DOI https://dx.doi.org/10.2174/157340909789054685 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Target Recognition in SAR Image by Joint Classification of Target Region and Shadow
Recent Advances in Electrical & Electronic Engineering Harnessing Immunologic Tools to Treat Gynecologic Disorders
Current Women`s Health Reviews Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Glycine Transporter Type-1 and its Inhibitors
Current Medicinal Chemistry Synthesis, Antimicrobial and Pharmacological Evaluation of Thioureaderivatives of 4H-1,2,4-triazole
Letters in Drug Design & Discovery The Effect of Plant Metabolites on Coronaviruses: A Comprehensive Review Focusing on their IC<sub>50</sub> Values and Molecular Docking Scores
Mini-Reviews in Medicinal Chemistry Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update
Anti-Infective Agents Proteomic and Bioinformatics Tools to Understand Virulence Mechanisms in Staphylococcus aureus
Current Proteomics P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors
Letters in Drug Design & Discovery A Novel Supperparamagnetic Heterogeneous Organocatalyst for the Efficient Synthesis of 3,3-́ diaryloxindoles
Current Organocatalysis Structure-Activity Relationships and Rational Design Strategies for Radical- Scavenging Antioxidants
Current Computer-Aided Drug Design Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Role of the Clinical Data Managers During the COVID-19 Pandemic: An Overview
Reviews on Recent Clinical Trials Cytoprotective Effects of 5 Benzophenones and a Xanthone from Hypericum annulatum in Models of Epirubicin-Induced Cytotoxicity: SARAnalysis and Mechanistic Investigations
Medicinal Chemistry Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review
Current Vascular Pharmacology COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews